Relay Therapeutics (RLAY) Revenue (2021 - 2026)
Relay Therapeutics (RLAY) reported Revenue of $3.0 million for Q1 2026, down 60.93% year-over-year from $7.7 million in Q1 2025, and down 57.14% quarter-over-quarter from $7.0 million in Q4 2025.
Relay Therapeutics (RLAY) Revenue (2021 - 2026) Analysis & Trends
Relay Therapeutics (RLAY) has 6 years of Revenue data on file, last reported at $3.0 million in Q1 2026.
- Revenue for Q1 2026 came in at $3.0 million, down 60.93% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.7 million (up 39.04% YoY), and the FY2025 annual result was $15.4 million, up 53.44% from the prior year.
- Revenue retreated to $3.0 million in Q1 2026 per RLAY's latest filing, from $7.0 million in the prior quarter.
- Over five years, Revenue peaked at $25.2 million in Q3 2023 and troughed at -$1000.0 in Q4 2023.
- A 5-year average of $4.3 million and a median of $419000.0 in 2022 frame the typical range for Revenue.
- On a YoY basis, Revenue climbed as much as 7226.16% in 2023 and fell as far as 100.4% in 2023.
- A 5-year view of Revenue shows it stood at $253000.0 in 2022, then sank by 100.4% to -$1000.0 in 2023, then surged by 1000800.0% to $10.0 million in 2024, then tumbled by 30.05% to $7.0 million in 2025, then plunged by 57.14% to $3.0 million in 2026.
- Business Quant data shows RLAY's Revenue at $3.0 million in Q1 2026, $7.0 million in Q4 2025, and $677000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 5.21 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 306.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 2.99 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Relay Therapeutics | 2.86 Bn | 2.86 Bn | - | 3.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.00 Mn |
| Dec 31, 2025 | 7.00 Mn |
| Jun 30, 2025 | 677,000.00 |
| Mar 31, 2025 | 7.68 Mn |
| Mar 31, 2024 | 10.01 Mn |
| Dec 31, 2023 | -1,000.00 |
| Sep 30, 2023 | 25.20 Mn |
| Jun 30, 2023 | 119,000.00 |
| Mar 31, 2023 | 226,000.00 |
| Dec 31, 2022 | 253,000.00 |
| Sep 30, 2022 | 344,000.00 |
| Jun 30, 2022 | 365,000.00 |
| Mar 31, 2022 | 419,000.00 |
| Dec 31, 2021 | 567,000.00 |
| Sep 30, 2021 | 666,000.00 |
| Jun 30, 2021 | 844,000.00 |
| Mar 31, 2021 | 952,000.00 |